Hyperfine 2025 Q2 Earnings Narrowed Losses but Weak Revenue

Hyperfine (HYPR) reported fiscal 2025 Q2 earnings on August 13th, 2025, showcasing a reduction in losses but a significant drop in revenue. The company’s leadership emphasized key product developments and a path to future growth.

Hyperfine’s Q2 2025 earnings revealed a mixed performance, with revenue declining sharply but losses narrowing. The reported $0.12 per share loss marked an improvement from $0.14 in the prior-year period, while net loss fell by 9.2% to $9.22 million. Despite these improvements, the company continues to face challenges in achieving profitability.

Revenue

Hyperfine’s total revenue for Q2 2025 declined by 25.8% to $2.70 million compared to $3.63 million in Q2 2024. Device sales accounted for the majority of revenue at $2.13 million, while services contributed $568,000. The drop in device sales reflects ongoing market and operational challenges.

Earnings/Net Income

The company narrowed its per-share loss to $0.12 in Q2 2025 from $0.14 in the same period the previous year, representing a 14.3% improvement. Net loss also decreased by 9.2% to $9.22 million compared to $10.16 million a year ago. However, these improvements do not signal a turnaround, as the company has posted losses for five consecutive years during this quarter.

Price Action

Hyperfine’s stock demonstrated significant volatility in the recent period, with an 8.55% gain over the week and a 58.75% surge month-to-date as of August 13th, 2025.

Post-Earnings Price Action Review

Strategies based on buying Hyperfine shares after a revenue increase quarter-over-quarter have historically underperformed. Over the past three years, such a strategy returned -21.14%, lagging the 46.32% benchmark return. The excess return of -67.46% and a CAGR of -7.87% reflect poor performance. The Sharpe ratio of -0.08 and maximum drawdown of 0.00% further highlight the high-risk, low-reward nature of this strategy.

CEO Commentary

Maria Sainz, CEO, described Q2 2025 as a transformative quarter for Hyperfine, driven by the FDA clearance of two new technologies and the launch of the next-generation Swoop system with Optive AI software. Sainz noted that the improved image quality is "transformative," allowing for broader adoption in hospitals, offices, and international markets. The completion of an office pilot program and the start of commercial sales in the U.S. office setting were also highlighted. Sainz expressed optimism that the company has reached an inflection point, with the new product launches and commercial execution unlocking a "$6 billion market opportunity." She reiterated confidence in the Swoop system's ability to alleviate MRI bottlenecks and deliver clinical value while expanding into international markets. Sainz stressed that the second half of 2025 would be "exciting," with a focus on revenue growth and margin expansion.

Guidance

Brett Hale, CFO, guided for full-year 2025 revenue growth of 10% to 20% over 2024, with a significant step-up expected in the second half. Revenue is projected to accelerate in Q3 and more significantly in Q4, with Q3 growth expected to be 50% higher than the Q1 to Q2 improvement. Gross margin is anticipated to range between 47% and 50% for the year, with potential to "comfortably and sustainably surpass 50%." Total cash burn is forecasted at $27 million to $29 million, a 27% year-over-year decline, with the company maintaining a cash runway through the end of 2026.

Additional News

Recent developments included Nigeria's telecom regulator calling for public support to protect infrastructure, Nigeria temporarily closing its border with Niger Republic for security and electoral reasons, and Bitcoin hitting a record high above $124,000 driven by favorable US legislation. Political developments such as the dismissal of chances for the ADC coalition to unseat President Tinubu were also reported, alongside infrastructure and policy updates across various Nigerian states.